{"id":"NCT00830960","sponsor":"Eli Lilly and Company","briefTitle":"A Comparison of Antiplatelet Therapies in Asian Subjects With Acute Coronary Syndrome","officialTitle":"A Comparison of Platelet Inhibition Following Prasugrel or Clopidogrel Administration in Asian Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-02","primaryCompletion":"2010-06","completion":"2010-06","firstPosted":"2009-01-28","resultsPosted":"2011-11-02","lastUpdate":"2011-11-02"},"enrollment":720,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Acute Coronary Syndrome"],"interventions":[{"type":"DRUG","name":"Prasugrel","otherNames":["LY640315","Effient","Efient","CS-747"]},{"type":"DRUG","name":"Clopidogrel","otherNames":["Plavix"]}],"arms":[{"label":"Prasugrel 60/10 Primary","type":"EXPERIMENTAL"},{"label":"Prasugrel 30/7.5 Primary","type":"EXPERIMENTAL"},{"label":"Prasugrel 30/5 Primary","type":"EXPERIMENTAL"},{"label":"Clopidogrel 300/75 Primary","type":"ACTIVE_COMPARATOR"},{"label":"Prasugrel 30/5 Low Weight/Elderly","type":"EXPERIMENTAL"},{"label":"Clopidogrel 300/75 Low Weight/Elderly","type":"ACTIVE_COMPARATOR"}],"summary":"The study will compare the safety and efficacy of prasugrel, administered at different doses with clopidogrel in the treatment of Asian participants with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention.","primaryOutcome":{"measure":"Adenosine Diphosphate (ADP)-Induced P2Y12 Receptor-mediated Platelet Aggregation (P2Y12 Reaction Units; PRU) Using the Accumetrics VerifyNow (VN) P2Y12 Assay at 4 Hours Post-Loading Dose (LD) in Primary Cohort (â‰¥60 kg and <75 Years)","timeFrame":"At 4 hours following LD administration","effectByArm":[{"arm":"Prasugrel 60-mg LD Primary","deltaMin":88.5,"sd":104.86},{"arm":"Prasugrel 30-mg LD Primary","deltaMin":124.2,"sd":117.28},{"arm":"Clopidogrel 300-mg LD Primary","deltaMin":261.8,"sd":83.87}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG001 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":7},"locations":{"siteCount":19,"countries":["China","South Korea","Taiwan","Thailand"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":117},"commonTop":["Cough","Pyrexia","Chest discomfort","Dyspnoea","Ecchymosis"]}}